Company Announcements In May, Bruker opened a new Singapore Center of Excellence, which provides sales and after-sales services for Southeast Asia. The Center has a staff of 45 and expects to hire 10 to 20 more employees. Bruker opened in May a major applications, training and service center in Shanghai, China. The center brings together […]
Swedish health care companies are bypassing venture capital financing to raise funds due to a weak venture capital environment. According to SwedenBIO, a survey of 19 public and 100 private companies found that 50% of them plan to raise up to SEK 50 million ($8 million) of funding over three years. However, that may be […]
It could take more than a year for things to return to normal at Japanese universities after the March earthquake and tsunami. The damage of universities in eastern Japan may be as high as ¥90 billion ($1.1 billion). Engineering school Tohoku University endured ¥77 billion in damage. Twenty-eight buildings require reconstruction. The government has created […]
A July 6 vote on a new food-labeling system will provide more information for EU consumers. Currently, beef, fresh fruit and vegetable packages, fish, olive oil and honey sold in the EU require labels revealing their country of origin. The new legislation will extend such labels to poultry, pork and lamb, and the European Commission […]
Costco Wholesale and Beef Products are two companies that have opted to take action rather than wait for the US government to uphold its promise to strengthen consumers’ protection from E. coli. E. coli prevention previously concentrated on one prevalent strain of the bacteria, O157:H7. The US Department of Agriculture’s proposal for how to address […]
Despite drug R&D spending falling to a three-year low of $68 billion in 2010, pharmaceutical sales grew to a record $856 billion. Drug companies are spending 22% of global sales, of which only 5% come from products new to market over the past five years, on R&D. In 2010, 21 new molecular entities were introduced, […]
Renewable energy investments continued to grow in 2010, according to the latest “Global Trends in Renewable Energy Investment” report. In 2010, $211 billion was spent on renewable energy, an increase of almost a third due to stimulus funding, new guidelines, wind farm development and small-scale rooftop solar PV installation. Asset financing grew 19% to $128 […]
R&D spending bounced back last year following the recession. In 2010, total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and laboratory product companies grew 11.3% to $1.54 billion, compared with 2.3% growth for the same companies in 2009. R&D spending for these companies was accelerated by higher […]
First-quarter revenues for the IBO Lab Equipment/Consumables Index grew 3.9%, 2.9% organically, to $3,970.74 million. Operating profit improved 4.0% to $707.69 million, and operating margin added 30 basis points to 18.2% of sales. Diploma was removed from the Index, and Merck Millipore was added. Biohit’s first-quarter sales grew 9.9%, 7.5% excluding currency, to €10.4 million […]
Venlo, the Netherlands and Melbourne, Australia 7/11/11— QIAGEN has increased its offer to acquire diagnostics maker Cellestis (see IBO 4/15/11). QIAGEN increased the offer price by 7% to AUD 3.80 ($3.96 =AUD 0.96 = $1) per share for a value of $374 million. QIAGEN stated that this would be its final offer absent a competing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
